Market Place
Sourcing Support
J&J Defeats Generic Drugmakers in Appeal Over Schizophrenia Drug
09 Jul 2025 //
REUTERS
J&J & Lilly Concealed Breast Cancer Risks in Antipsychotics Drug
24 Apr 2025 //
PR NEWSWIRE
J&J hit with new class action over talc seeking medical monitoring for cancer
18 Jun 2024 //
REUTERS
US FDA mandates label updates on CAR-T cancer therapies
19 Apr 2024 //
REUTERS
Teva, Viatris win new chance to challenge J&J schizophrenia drug patent
02 Apr 2024 //
REUTERS
RYBREVANT data at ELCC advance J&J`s ambition to transform the standard of care for patients with NSCLC
18 Mar 2024 //
PR NEWSWIRE
J&J unloads certain Ponvory rights to Vanda for $100M
08 Dec 2023 //
FIERCE PHARMA
Janssen Aims to Define Standards of Care in the Treatment of Solid Tumor Cancers
16 Oct 2023 //
PRESS RELEASE
Sandoz inks deal to commercialize biosim to J&J`s Stelara
12 Sep 2023 //
FIERCE PHARMA
McKesson Dangles $1 Billion Legal Fund to Boost Opioid Deal
22 Feb 2020 //
BLOOMBERGQUINT
Pfizer, Astellas` Xtandi matches J&J`s Erleada with new FDA nod
17 Dec 2019 //
FIERCE PHARMA
J&J finds competitive edge with latest Erleada approval
19 Sep 2019 //
BIOPHARMADIVE
Novartis, Lonza deepen biosimilars push with MS, arthritis drug deals
04 Sep 2019 //
REUTERS
Democrat Harris unveils plan to lower drug costs, put `people over profit`
17 Jul 2019 //
REUTERS
Gilead schemed with J&J, BMS to protect HIV combos: lawsuit
15 May 2019 //
FIERCE PHARMA
Lawsuit accuses Gilead of propping up cost of lifesaving HIV treatments
14 May 2019 //
CNBC
J&J, under `accelerating` generic & biosim attack, expects growth in 2019
16 Apr 2019 //
FIERCE PHARMA
Andexxa will go nationwide with FDA nod on Portola`s commercial production
03 Jan 2019 //
FIERCE PHARMA
J&J unit to pay $360 million to U.S. to resolve charity kickback probe
07 Dec 2018 //
REUTERS
Generic threat looms to J&J’s blockbuster Zytiga in US
24 Nov 2018 //
PMLIVE
U.S. appeals court declines J&J bid to stop generic Zytiga sales
22 Nov 2018 //
REUTERS
Johnson & Johnson down to its final Zytiga defenses
30 Oct 2018 //
FIERCE PHARMA
Johnson & Johnson loses Zytiga patent dispute, appeal planned
30 Oct 2018 //
SEEKING ALPHA
Teva`s Copaxone holds its own in wake of Mylan`s generic price cut
02 Aug 2018 //
FIERCE PHARMA
GSK, J&J CEOs invited to dinner during Trump U.K. visit: FT
05 Jul 2018 //
FIERCE PHARMA
Who’s delaying generic competition? FDA publishes list of drugmakers
17 May 2018 //
ENDPTS
With Generic and Over-the-Counter Viagra Coming, Pfizer Looks for a Viable
02 Apr 2018 //
BIOSPACE
France fines J&J 25 million euros over painkiller patch
21 Dec 2017 //
REUTERS
Pharma`s unit sales and spins are back in style
20 Dec 2017 //
FIERCE PHARMA
U.S. court upholds Takeda patent on cancer drug Velcade
18 Jul 2017 //
REUTERS
Novartis stocks drug cabinet with "Big-3" arthritis blockbusters
15 Jul 2017 //
REUTERS
Valeant could be hit hardest by FDA generics push: analyst
28 Jun 2017 //
FIERCE PHARMA
Mylan cuts short J&J`s Concerta generics reprieve with new FDA nod
26 Oct 2016 //
FIERCE PHARMA
Generic Drug Makers Challenge FDA Plan to Withdraw their ADHD Pills
25 Oct 2016 //
STAT
J&J gets FDA approval for continuous manufacturing of Prezista
11 Apr 2016 //
FIERCE PHARMA MANUFACTURING
J&J: Biosimilars will not replicate generic levels of competition or substitution
15 Sep 2015 //
BIOPHARMA-REPORTER
Vyvanse set to steal ADHD share in back-to-school meds rush
19 Aug 2015 //
FIERCE PHARMA MARKETING
Generics maker Amneal revamping former J&J plant in Ireland
04 Aug 2015 //
FIERCE PHARMA MANUFACTURING
AstraZeneca isn`t giving up on brodalumab despite its links to suicide
01 Aug 2015 //
FIERCE BIOTECH
Analyst: J&J`s Stelara to challenge Novartis in ankylosing spondylitis
27 Jul 2015 //
FIERCE PHARMA
Two big problems with generic-drug substitution
23 Jun 2015 //
CNBC
FDA balks on generic Concerta as Mallinckrodt, Actavis meds gobble up market
18 Jun 2015 //
FIERCE PHARMA
Will Mylan`s $29B Bid Spur Other Perrigo Suitors To Enter The Fray?
10 Apr 2015 //
FIERCE PHARMA
Celltrion Seeks FDA Approval for Biosimilar Remsima
01 Apr 2015 //
FIRST WORLD PHARMA
